dimethyl sulfoxide has been researched along with Telangiectasia, Hereditary Hemorrhagic in 1 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Telangiectasia, Hereditary Hemorrhagic: An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimoda, Y | 1 |
| Osanai, T | 1 |
| Nakayama, N | 1 |
| Ushikoshi, S | 1 |
| Hokari, M | 1 |
| Shichinohe, H | 1 |
| Abumiya, T | 1 |
| Kazumata, K | 1 |
| Houkin, K | 1 |
1 other study available for dimethyl sulfoxide and Telangiectasia, Hereditary Hemorrhagic
| Article | Year |
|---|---|
De novo arteriovenous malformation in a patient with hereditary hemorrhagic telangiectasia.
Topics: Age of Onset; Arteriovenous Fistula; Child, Preschool; Dimethyl Sulfoxide; Embolization, Therapeutic | 2016 |